These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10687772)

  • 1. Choriocarcinoma developing after prolonged molar surveillance.
    Nada W; Parker J; Carter J
    Aust N Z J Obstet Gynaecol; 1999 Nov; 39(4):490-2. PubMed ID: 10687772
    [No Abstract]   [Full Text] [Related]  

  • 2. Natural history of hydatidiform mole after primary evacuation.
    Lurain JR; Brewer JI; Torok EE; Halpern B
    Am J Obstet Gynecol; 1983 Mar; 145(5):591-5. PubMed ID: 6829636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydatidiform mole. A follow-up regimen for identification of invasive mole and choriocarcinoma and for selection of patients for treatment.
    Brewer JI; Torok EE; Webster A; Dolkart RE
    Am J Obstet Gynecol; 1968 Jun; 101(4):557-63. PubMed ID: 5690298
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnostic image (28). Hydatidiform mole].
    Blaauwgeers JL; Bais JM
    Ned Tijdschr Geneeskd; 2001 Mar; 145(10):477. PubMed ID: 11268910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choriocarcinoma following ovarian hydatidiform mole: a case report.
    Joneborg U; Papadogiannakis N; Lindell G; Marions L
    J Reprod Med; 2011; 56(11-12):511-4. PubMed ID: 22195336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
    Yuen BH; Cannon W; Benedet JL; Boyes DA
    Am J Obstet Gynecol; 1977 Apr; 127(7):711-2. PubMed ID: 557901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of combined use of ultrasonography and beta-hCG determination in diagnosis of pelvic lesions of malignant trophoblastic disease].
    Fu QZ; Jiang S
    Zhonghua Fu Chan Ke Za Zhi; 1990 Nov; 25(6):352-4, 383-4. PubMed ID: 2178083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum progesterone and serum chorionic gonadotrophin in hydatidiform mole and choriocarcinoma.
    Teoh ES; Das NP; Dawood MY; Ratnam SS
    Acta Endocrinol (Copenh); 1972 Aug; 70(4):791-800. PubMed ID: 5068403
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical presentation and management of molar pregnancy.
    Sasaki S
    Best Pract Res Clin Obstet Gynaecol; 2003 Dec; 17(6):885-92. PubMed ID: 14614887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum human chorionic somatomammotropin in unaborted hydatidiform mole.
    Dawood MY; Teoh ES
    Obstet Gynecol; 1976 Feb; 47(2):183-8. PubMed ID: 1250540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative chorionic gonadotrophin; prognostic value in hydatidiform mole and chorionepithelioma.
    DELFS E
    Obstet Gynecol; 1957 Jan; 9(1):1-24. PubMed ID: 13388200
    [No Abstract]   [Full Text] [Related]  

  • 12. [Case report of ultrasonographic findings in developing choriocarcinoma].
    Nikolić B; Lazić J; Lacković V
    Med Arh; 2006; 60(4):269-70. PubMed ID: 16761526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioimmunoassay of hCG as an early diagnosis of cerebral metastases in choriocarcinoma patients.
    Soma H; Takayama M; Tokoro K; Kikuchi T; Kikuchi K; Saegusa H
    Acta Obstet Gynecol Scand; 1980; 59(5):445-8. PubMed ID: 7446011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HCG in patients with hydatidiform mole or chorionepithelioma].
    Rjosk HK; Gokel JM; Holzmann K
    Arch Gynecol; 1979 Jul; 228(1-4):667-8. PubMed ID: 485551
    [No Abstract]   [Full Text] [Related]  

  • 15. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole.
    Medeiros F; Callahan MJ; Elvin JA; Dorfman DM; Berkowitz RS; Quade BJ
    Int J Gynecol Pathol; 2008 Apr; 27(2):247-51. PubMed ID: 18317216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hydatidiform mole, trophoblastic tumor/choriocarcinoma].
    Luschin-Ebengreuth G; Petru E; Pickel H
    Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():125-6. PubMed ID: 1337488
    [No Abstract]   [Full Text] [Related]  

  • 17. Complementary role of sonography and arteriography in management of uterine choriocarcinoma.
    Levin DC; Staiano S; Schneider M; Becker JA
    Am J Roentgenol Radium Ther Nucl Med; 1975 Oct; 125(2):462-8. PubMed ID: 1239196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative urine hCG in choriocarcinoma.
    Olaniyan OB; Momoh JA
    Int J Gynaecol Obstet; 2007 Jul; 98(1):59-60. PubMed ID: 17481634
    [No Abstract]   [Full Text] [Related]  

  • 19. Gestational trophoblastic disease. A comparative study of the results of therapy in patients with invasive mole and with choriocarcinoma.
    Brewer JI; Eckman TR; Dolkart RE; Torok EE; Webster A
    Am J Obstet Gynecol; 1971 Jan; 109(2):335-40. PubMed ID: 5539127
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.